SCHEMBL8858484

SCHEMBL8858484

O=C(O)COc1cccc2c1CCC2CCO

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 17/20 0.61
TBXAS1 P24557 1/20 0.53
PTGDR2 Q9Y5Y4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9155513 0.94 PTGIR (0.69) PTGIRTBXAS1PTGDR2
SCHEMBL8858587 0.86 PTGIR (0.72) PTGIRTBXAS1PTGDR2
SCHEMBL8414336 0.86 PTGIR (0.49) PTGIRTBXAS1
SCHEMBL9155480 0.85 PTGIR (0.68) PTGIRTBXAS1PTGDR2
SCHEMBL9050868 0.84 PTGIR (0.64) PTGIRTBXAS1PTGDR2
SCHEMBL9151307 0.81 PTGIR (0.63) PTGIRTBXAS1PTGDR2
SCHEMBL9017264 0.81 PTGIR (0.63) PTGIRTBXAS1PTGDR2
SCHEMBL8411209 0.80 PTGIR (0.56) PTGIRTBXAS1
SCHEMBL9050358 0.80 PTGIR (0.43) PTGIR
SCHEMBL8811047 0.80 ACHE (0.45) PTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5596009-A TREATMENT OF THROMBOSIS, ATHERIOSCLEROSIS, ANTIISCHEMIC AGENTS, ANTIULCER AGENTS OR HYPOTENSIVE AGENTS ONO PHARMACEUTICAL CO., LTD. (JP) 1997-01-21 US disclosed
EP-0542203-B1 Fused benzeneoxyacetic acid derivatives as PGl2 receptor agonists ONO PHARMACEUTICAL CO (JP) 1996-07-03 EP disclosed
US-5389666-A Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension ONO PHARMACEUTICAL CO., LTD. (JP) 1995-02-14 US disclosed
US-5344836-A Fused benzeneoxyacetic acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1994-09-06 US disclosed